Related Experiment Videos
GenStar: a method for de novo drug design
1Vertex Pharmaceuticals Incorporated, Cambridge, MA 02139.
Journal of Computer-Aided Molecular Design
|February 1, 1993
Summary
GenStar is a new computational method that designs novel, low-energy molecules to fit enzyme active sites. This approach aids in discovering new drug candidates by generating chemically sound structures with good enzyme interactions.
Area of Science:
- Computational chemistry
- Drug discovery
- Structural biology
Background:
- Enzyme active site filling is crucial for drug design.
- Generating novel, chemically valid molecules with desired properties is challenging.
Purpose of the Study:
- To introduce GenStar, a novel computational method for generating chemically reasonable molecular structures tailored for enzyme active sites.
Main Methods:
- GenStar utilizes sequential growth of sp3 carbon atoms, allowing branching and ring formation.
- Structure generation can be initiated from user-defined enzyme seed atoms or a predocked inhibitor core.
- Candidate atom positions are evaluated using an enzyme contact model, with selection based on high scores.
Main Results:
- GenStar successfully generated structures with good steric contact and low-energy conformations.
- The method demonstrated its capability by producing structures similar to known potent inhibitors for HIV protease, FKBP-12, and HCA-II.
- Analysis of generated compounds can reveal binding motifs for common molecular fragments.
Conclusions:
- GenStar offers a novel and effective approach for de novo design of enzyme-inhibiting molecules.
- The method has the potential to accelerate the discovery of new therapeutic agents.
- GenStar's ability to generate diverse and relevant structures makes it a valuable tool in medicinal chemistry.